REGISTERED NUMBER: 04165383 (England and Wales)

Financial Statements

for the Year Ended 31 March 2025

for

Heath Pharmacy Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

H Patel

P Takkallapally

REGISTERED OFFICE:

57 New Walk

Leicester

LE1 7EA

REGISTERED NUMBER:

04165383 (England and Wales)

Fixed assets

Intangible assets

4

-

-

Tangible assets

5

15,553

16,923

15,553

16,923

Current assets

Stocks

41,114

57,068

Debtors: amounts falling due within one year

6

350,781

20,734

Cash at bank and in hand

49,418

185,818

441,313

263,620

Creditors

Amounts falling due within one year

7

290,791

208,932

Net current assets

150,522

54,688

Total assets less current liabilities

166,075

71,611

Provisions for liabilities

2,112

1,994

Net assets

163,963

69,617

Capital and reserves

Called up share capital

1,000

1,000

Retained earnings

162,963

68,617

163,963

69,617

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 September 2025 and were signed on its behalf by:

H Patel - Director

P Takkallapally - Director

1.	Statutory information

Heath Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	Employees and directors

The average number of employees during the year was 9 (2024 - 9 ) .

4.	Intangible fixed assets

Goodwill

£

Cost

At 1 April 2024

and 31 March 2025

300,000

Amortisation

At 1 April 2024

and 31 March 2025

300,000

Net book value

At 31 March 2025

-

At 31 March 2024

-

5.	Tangible fixed assets

Improvements

Fixtures

to

and

Motor

Computer

property

fittings

vehicles

equipment

Totals

£

£

£

£

£

Cost

At 1 April 2024

39,796

35,390

1,200

19,499

95,885

Additions

-

719

-

3,542

4,261

At 31 March 2025

39,796

36,109

1,200

23,041

100,146

Depreciation

At 1 April 2024

33,368

29,463

799

15,332

78,962

Charge for year

1,990

997

100

2,544

5,631

At 31 March 2025

35,358

30,460

899

17,876

84,593

Net book value

At 31 March 2025

4,438

5,649

301

5,165

15,553

At 31 March 2024

6,428

5,927

401

4,167

16,923

6.

Debtors: amounts falling due within one year

31.3.25

31.3.24

£

£

Trade debtors

(91

)

577

Chemix Group Limited

292,710

-

Trimdon Healthcare Ltd

22,249

-

VAT

35,913

20,157

350,781

20,734

7.

Creditors: amounts falling due within one year

31.3.25

31.3.24

£

£

Bank loans and overdrafts

73

-

Trade creditors

160,839

141,182

Tax

71,037

28,975

Social security and other taxes

2,609

2,639

Other creditors

-

14,444

Chemix Group Limited

-

10,058

Middleton Healthcare Ltd

44,980

-

Directors' loan accounts

7,253

6,629

Accrued expenses

4,000

5,005

290,791

208,932